Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.8900
+0.0200
+(1.07%)
At close: 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | -0.13 | -0.13 | -0.56 | -0.62 |
| Low Estimate | -0.13 | -0.13 | -0.56 | -0.8 |
| High Estimate | -0.13 | -0.13 | -0.56 | -0.45 |
| Year Ago EPS | -- | -- | -1.17 | -0.56 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0 | -0.32 | -0.31 | -- |
| EPS Actual | -0.34 | -0.36 | -0.25 | -0.22 |
| Difference | -0.34 | -0.04 | 0.05 | -- |
| Surprise % | 0.00% | -12.50% | 18.03% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.13 | -0.13 | -0.56 | -0.62 |
| 7 Days Ago | -0.18 | -0.18 | -0.75 | 0 |
| 30 Days Ago | -0.18 | -0.18 | -0.75 | 0 |
| 60 Days Ago | -0.18 | -0.18 | -0.75 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INTS | -- | -- | 52.14% | -11.61% |
| S&P 500 | 6.56% | 6.52% | 9.72% | 14.29% |
Upgrades & Downgrades
| Initiated | Alliance Global Partners: Buy | 1/13/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/21/2024 |
| Initiated | HC Wainwright & Co.: Buy | 10/31/2024 |
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 7/11/2024 |
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 5/16/2024 |
| Reiterates | Benchmark: Speculative Buy to Speculative Buy | 3/21/2024 |
Related Tickers
ALA.AX Arovella Therapeutics Limited
0.0700
-9.09%
NBIO Nascent Biotech, Inc.
0.0065
+44.44%
LTP.AX LTR PHARMA FPO [LTP]
0.3300
-9.59%
GDTC CytoMed Therapeutics Limited
2.3800
+0.42%
FNCH Finch Therapeutics Group, Inc.
13.16
-2.52%
EPRX Eupraxia Pharmaceuticals Inc.
3.0000
+2.74%
BYSI BeyondSpring Inc.
1.1500
-15.44%
ARDS Aridis Pharmaceuticals, Inc.
0.0001
0.00%
OCS Oculis Holding AG
14.37
-7.29%
NEUP Neuphoria Therapeutics Inc.
4.6400
-9.73%